MiMedx Group, Inc. (MDXG)
3.06
-0.05
(-1.61%)
USD |
NASDAQ |
Nov 20, 16:00
3.05
-0.01
(-0.33%)
After-Hours: 19:36
MiMedx Group Gross Profit (TTM) : 233.73M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 233.73M |
| June 30, 2026 | 279.22M |
| March 31, 2026 | 314.95M |
| December 31, 2025 | 345.18M |
| September 30, 2025 | 322.07M |
| June 30, 2025 | 295.72M |
| March 31, 2025 | 288.06M |
| December 31, 2024 | 288.04M |
| September 30, 2024 | 285.04M |
| June 30, 2024 | 283.23M |
| March 31, 2024 | 278.55M |
| December 31, 2023 | 266.08M |
| September 30, 2023 | 253.11M |
| June 30, 2023 | 241.70M |
| March 31, 2023 | 229.10M |
| December 31, 2022 | 218.82M |
| September 30, 2022 | 215.48M |
| June 30, 2022 | 212.91M |
| March 31, 2022 | 213.21M |
| December 31, 2021 | 214.51M |
| September 30, 2021 | 215.50M |
| June 30, 2021 | 216.49M |
| March 31, 2021 | 206.48M |
| December 31, 2020 | 207.83M |
| September 30, 2020 | 211.98M |
| Date | Value |
|---|---|
| June 30, 2020 | 231.81M |
| March 31, 2020 | 242.18M |
| December 31, 2019 | 247.68M |
| September 30, 2019 | 266.02M |
| June 30, 2019 | 270.38M |
| March 31, 2019 | 299.43M |
| December 31, 2018 | 315.81M |
| September 30, 2018 | 313.91M |
| June 30, 2018 | 310.54M |
| March 31, 2018 | 293.21M |
| December 31, 2017 | 283.23M |
| September 30, 2017 | 265.74M |
| June 30, 2017 | 246.98M |
| March 31, 2017 | 229.21M |
| December 31, 2016 | 210.48M |
| September 30, 2016 | 196.53M |
| June 30, 2016 | 184.53M |
| March 31, 2016 | 175.39M |
| December 31, 2015 | 166.16M |
| September 30, 2015 | 155.29M |
| June 30, 2015 | 141.42M |
| March 31, 2015 | 123.67M |
| December 31, 2014 | 104.63M |
| September 30, 2014 | 83.51M |
| June 30, 2014 | 67.31M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Anika Therapeutics, Inc. | 78.26M |
| Perspective Therapeutics, Inc. | -4.251M |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | -0.4841M |
| Enovis Corp. | 1.235B |